Industry-Sponsored IND Filings Jump In 2004
Pharmaceutical industry sponsored INDs jumped by almost 40% in 2004, the upcoming Parexel Pharmaceutical R&D Statistical Sourcebook shows
You may also be interested in...
The pharmaceutical industry is continuing to face declining output from its R&D investment
Industry-sponsored IND submissions are running at their lowest level in seven years
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011